JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB139436

Akt Kinase Activity Assay试剂盒

Akt Kinase Activity Assay Kit

Be the first to review this product! Submit a review

|

(19 Publications)

Akt Kinase Activity Assay Kit (ab139436) is a non-radioactive assay providing a safe, rapid and reliable method for the screening of inhibitors or activators of Akt and for quantitating the activity of Akt in purified or partially purified enzyme preparations.

查看别名

PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha

1 Images
Functional Studies - Akt Kinase Activity Assay Kit (AB139436)
  • FuncS

Supplier Data

Functional Studies - Akt Kinase Activity Assay Kit (AB139436)

Varying quantities of purified active Akt were assayed using the Akt substrate microtiter plate. Assays were incubated for 60 minutes at 30°C.

关键信息

检测方法

Colorimetric

样品类型

Purified protein, Suspension cells, Tissue Extracts, Adherent cells

检测类型

Enzyme activity

检测平台

Microplate reader

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Enzyme activity assay": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

产品详情

Akt Kinase Activity Assay Kit (ab139436) is a non-radioactive assay providing a safe, rapid and reliable method for the screening of inhibitors or activators of Akt and for quantitating the activity of Akt in purified or partially purified enzyme preparations. This kit is based on a solid phase enzyme-linked immuno-absorbent assay (ELISA) that utilizes a specific synthetic peptide as a substrate for Akt and a polyclonal antibody that recognizes the phosphorylated form of the substrate. The assay is designed for the analysis of Akt activity in the solution phase. For the measurement of Akt in partially purified and purified enzyme preparations from any species.

The kit offers the following advantages:

1. Safe - non-radioactive measurement of kinase activity

2. Flexible - kinetic and end-point options available

3. Fast - results in < 4.5 hours

4. Efficient - only 30 μl diluted sample needed per well

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

精确度

[ { "reproducibilityType": "Inter", "sample": "Sample", "replicates": 0, "mean": null, "standardDeviation": null, "coefficientOfVariability": "< 10" }, { "reproducibilityType": "Intra", "sample": "Sample", "replicates": 0, "mean": null, "standardDeviation": null, "coefficientOfVariability": "< 10" } ]

规格

{ "values": { "1x96Tests": { "sellingSize": "1 x 96 Tests", "publicAssetCode":"ab139436-1x96Tests", "assetComponentDetails": [ { "size":"1 x 10 mL", "name":"Stop Solution 2", "number":"AB139436-CMP07", "productcode":"" }, { "size":"1 x 30 mL", "name":"20X Wash Buffer", "number":"AB139436-CMP08", "productcode":"" }, { "size":"1 x 10 mL", "name":"TMB Substrate", "number":"AB139436-CMP09", "productcode":"" }, { "size":"1 x 10 mL", "name":"Antibody Dilution Buffer", "number":"AB139436-CMP01", "productcode":"" }, { "size":"1 x 10 mL", "name":"Kinase Assay Dilution Buffer", "number":"AB139436-CMP04", "productcode":"" }, { "size":"1 x 2 mg", "name":"ATP", "number":"AB139436-CMP03", "productcode":"" }, { "size":"1 x 1 Unit", "name":"Akt Substrate Microtiter Plate", "number":"AB139436-CMP06", "productcode":"" }, { "size":"1 x 30 µL", "name":"Active Akt", "number":"AB139436-CMP10", "productcode":"" }, { "size":"1 x 20 µL", "name":"Anti-Rabbit IgG: HRP Conjugate", "number":"AB139436-CMP02", "productcode":"" }, { "size":"1 x 5 mL", "name":"Akt Phosphospecific Substrate Antibody", "number":"AB139436-CMP05", "productcode":"" } ] } } }

性能和储存信息

运输条件
Dry Ice
推荐的短期储存条件
Multi
推荐的长期储存条件
Multi
储存信息
Please refer to protocols

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

AKT also known as protein kinase B (PKB) is a serine/threonine kinase with a molecular weight of approximately 56 kDa. It plays an important role in signaling pathways regulating cellular processes such as glucose uptake cell survival and growth. AKT is expressed in various tissues including muscle and liver and is often observed using techniques like Western blot. Its kinase activity involves phosphorylation which is essential for its full activation and subsequent biological functions.
Biological function summary

AKT influences cell proliferation and apoptosis. As part of a signaling complex AKT phosphorylation modulates several downstream targets important for cell cycle progression and survival. Its activation depends on upstream kinases like PI3K and PDK1 positioning AKT as a central node in cellular responses. By mediating these processes AKT directly impacts organismal growth and stress response mechanisms.

Pathways

AKT is central to the PI3K/AKT/mTOR and insulin signaling pathways both important for cellular metabolism and growth regulation. It interacts with proteins such as mTOR and GSK3 which are involved in cell growth and glycogen synthesis respectively. These interactions show AKT's pivotal role in maintaining cellular energy balance and metabolic processes.

AKT is frequently linked to cancer and type 2 diabetes. Its abnormal regulation contributes to oncogenesis through uncontrolled cell proliferation and survival. AKT is also associated with insulin resistance in diabetes where it affects glucose metabolism. Through these conditions proteins like PTEN and IRS1 interact with or regulate AKT highlighting its significance in disease states and its potential as a therapeutic target.

产品实验方案

靶点信息

AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed : 11882383, PubMed : 15526160, PubMed : 15861136, PubMed : 21432781, PubMed : 21620960, PubMed : 31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed : 11882383, PubMed : 15526160, PubMed : 21432781, PubMed : 21620960, PubMed : 29343641, PubMed : 31204173). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed : 11882383, PubMed : 15526160, PubMed : 21432781, PubMed : 21620960). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed : 11994271). AKT also regulates the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT also regulates cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed : 11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed : 11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating the mTORC1 signaling pathway, and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed : 12150915, PubMed : 12172553). Also regulates the mTORC1 signaling pathway by catalyzing phosphorylation of CASTOR1 and DEPDC5 (PubMed : 31548394, PubMed : 33594058). AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Part of a positive feedback loop of mTORC2 signaling by mediating phosphorylation of MAPKAP1/SIN1, promoting mTORC2 activation (By similarity). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed : 10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed : 10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed : 10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed : 9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed : 9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor 1 (IGF1) (PubMed : 12176338, PubMed : 12964941). AKT mediates the antiapoptotic effects of IGF1 (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed : 19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its : kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed : 17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its : cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed : 20086174). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed : 19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed : 10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed : 10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed : 23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed : 20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed : 18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed : 16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed : 16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed : 20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed : 32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors : forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed : 32228865). Acts as a regulator of mitochondrial calcium uptake by mediating phosphorylation of MICU1 in the mitochondrial intermembrane space, impairing MICU1 maturation (PubMed : 30504268). Acts as an inhibitor of tRNA methylation by mediating phosphorylation of the N-terminus of METTL1, thereby inhibiting METTL1 methyltransferase activity (PubMed : 15861136). In response to LPAR1 receptor pathway activation, phosphorylates Rabin8/RAB3IP which alters its activity and phosphorylates WDR44 which induces WDR44 binding to Rab11, thereby switching Rab11 vesicular function from preciliary trafficking to endocytic recycling (PubMed : 31204173).
See full target information AKT1

文献 (19)

Recent publications for all applications. Explore the full list and refine your search

Cancer medicine 13:e70031 PubMed39114948

2024

Mechanism and rational combinations with GP-2250, a novel oxathiazine derivative, in ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Mark S Kim,Deanna Glassman,Katelyn F Handley,Adrian Lankenau Ahumada,Nicholas B Jennings,Emine Bayraktar,Katherine Foster,Robiya Joseph,Sanghoon Lee,Robert L Coleman,Anil K Sood

Scientific reports 14:10039 PubMed38693166

2024

Structural investigation of Trypanosoma cruzi Akt-like kinase as drug target against Chagas disease.

Applications

Unspecified application

Species

Unspecified reactive species

Karina A Stadler,Lesly J Ortiz-Joya,Amit Singh Sahrawat,Christoph Buhlheller,Karl Gruber,Tea Pavkov-Keller,Treasa B O'Hagan,Alba Guarné,Sergio Pulido,Marcel Marín-Villa,Klaus Zangger,Nina Gubensäk

American journal of physiology. Cell physiology 326:C1237-C1247 PubMed38581667

2024

Extracellular glucose and dysfunctional insulin receptor signaling independently upregulate arterial smooth muscle TMEM16A expression.

Applications

Unspecified application

Species

Unspecified reactive species

Somasundaram Raghavan,Masuma Akter Brishti,Angelica Bernardelli,Alejandro Mata-Daboin,Jonathan H Jaggar,M Dennis Leo

Cellular and molecular life sciences : CMLS 81:24 PubMed38212432

2024

Lactic acid promotes nucleus pulposus cell senescence and corresponding intervertebral disc degeneration via interacting with Akt.

Applications

Unspecified application

Species

Unspecified reactive species

Yuyao Zhang,Libangxi Liu,Yuhan Qi,Jinhui Lou,Yuxuan Chen,Chao Liu,Haiyin Li,Xian Chang,Zhilei Hu,Yueyang Li,Yang Zhang,Chencheng Feng,Yue Zhou,Yu Zhai,Changqing Li

Cell death discovery 9:364 PubMed37779163

2023

Gastrodin overcomes chemoresistance via inhibiting Skp2-mediated glycolysis.

Applications

Unspecified application

Species

Unspecified reactive species

Li Xie,Jinzhuang Liao,Wenbin Liu,Ruirui Wang,Xiaoying Li,Wei Li,Zhongsu Zhou

Journal of pineal research 74:e12851 PubMed36639364

2023

Melatonin increases susceptibility to atrial fibrillation in obesity via Akt signaling impairment in response to lipid overload.

Applications

Unspecified application

Species

Unspecified reactive species

Xinghua Qin,Yuping Fu,Jiali Fan,Binghua Liu,Peng Liu,Yudi Zhang,Tiannan Jiang,Qiangsun Zheng

Pharmaceuticals (Basel, Switzerland) 15: PubMed35745619

2022

In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers.

Applications

Unspecified application

Species

Unspecified reactive species

Rana M Abdelnaby,Afaf A El-Malah,Rasha R FakhrEldeen,Marwa M Saeed,Rania I Nadeem,Nancy S Younis,Hanaa M Abdel-Rahman,Nehad M El-Dydamony

Pharmaceuticals (Basel, Switzerland) 15: PubMed35455425

2022

Dual PI3K/Akt Inhibitors Bearing Coumarin-Thiazolidine Pharmacophores as Potential Apoptosis Inducers in MCF-7 Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Rana M Abdelnaby,Heba S Rateb,Omaima Ali,Ahmed S Saad,Rania I Nadeem,Sahar M Abou-Seri,Kamilia M Amin,Nancy S Younis,Rasha Abdelhady

Journal of enzyme inhibition and medicinal chemistry 37:895-911 PubMed35345960

2022

Pyrimidine-5-carbonitrile based potential anticancer agents as apoptosis inducers through PI3K/AKT axis inhibition in leukaemia K562.

Applications

Unspecified application

Species

Unspecified reactive species

Nehad M El-Dydamony,Rana M Abdelnaby,Rasha Abdelhady,Omaima Ali,Mohamed I Fahmy,Rasha R Fakhr Eldeen,Amira A Helwa

Cell reports 38:110509 PubMed35294873

2022

Methylene-bridge tryptophan fatty acylation regulates PI3K-AKT signaling and glucose uptake.

Applications

Unspecified application

Species

Unspecified reactive species

Song-Hua Hu,Xia-Di He,Ji Nie,Jun-Li Hou,Jiang Wu,Xiao-Yan Liu,Yun Wei,Hui-Ru Tang,Wen-Xing Sun,Shu-Xian Zhou,Yi-Yuan Yuan,Yan-Peng An,Guo-Quan Yan,Yan Lin,Peng-Cheng Lin,Jean J Zhao,Ming-Liang Ye,Jian-Yuan Zhao,Wei Xu,Shi-Min Zhao
View all publications
websiteProtocolBooklet
en

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com